Archives
-
Cambridge Spin-out PharmEnable Raises £1.8 million for Drug Discovery Expansion
30 June, 2020
-
o2h ventures limited backed company AI VIVO identifies drugs for Covid-19 through its AI driven platform
17 April, 2020
-
Newsflash – COVID-19, o2h ventures Biotech Therapeutics and AI Fund
27 February, 2020
-
o2h ventures makes an investment in Turbine…
15 February, 2020
-
o2h ventures makes an investment in Pencil Biosciences a novel gene modulation biotech…
15 February, 2020
-
o2h ventures is pleased to announce an investment in Neurofenix, an innovative digital health company…
15 February, 2020
-
o2h ventures portfolio company Exonate announces collaboration with Johnson & Johnson
17 January, 2020
-
Sunil Shah, CEO, o2h discovery Wins Special Recognition Award by OBN UK Ltd
11 November, 2019
-
o2h ventures makes it to the finals in the Tax Efficiency Awards
17 October, 2019
invest in the growth potential of UK life science & AI